These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34935080)

  • 1. The neurochemical pathology of schizophrenia: post-mortem studies from dopamine to parvalbumin.
    Reynolds GP
    J Neural Transm (Vienna); 2022 Jun; 129(5-6):643-647. PubMed ID: 34935080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reductions in midbrain GABAergic and dopamine neuron markers are linked in schizophrenia.
    Purves-Tyson TD; Brown AM; Weissleder C; Rothmond DA; Shannon Weickert C
    Mol Brain; 2021 Jun; 14(1):96. PubMed ID: 34174930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D2 and D4 dopamine receptor mRNA distribution in pyramidal neurons and GABAergic subpopulations in monkey prefrontal cortex: implications for schizophrenia treatment.
    de Almeida J; Mengod G
    Neuroscience; 2010 Nov; 170(4):1133-9. PubMed ID: 20727949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of dopamine D2 receptors increases parvalbumin-positive interneurons in the anterior cingulate cortex.
    Graham DL; Durai HH; Garden JD; Cohen EL; Echevarria FD; Stanwood GD
    ACS Chem Neurosci; 2015 Feb; 6(2):297-305. PubMed ID: 25393953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-frontal parvalbumin interneurons in schizophrenia: a meta-analysis of post-mortem studies.
    Kaar SJ; Angelescu I; Marques TR; Howes OD
    J Neural Transm (Vienna); 2019 Dec; 126(12):1637-1651. PubMed ID: 31529297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of dopamine D
    Tomasella E; Bechelli L; Ogando MB; Mininni C; Di Guilmi MN; De Fino F; Zanutto S; Elgoyhen AB; Marin-Burgin A; Gelman DM
    Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3476-3481. PubMed ID: 29531031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships among parvalbumin-immunoreactive neuron density, phase-locked gamma oscillations, and autistic/schizophrenic symptoms in PDGFR-β knock-out and control mice.
    Nakamura T; Matsumoto J; Takamura Y; Ishii Y; Sasahara M; Ono T; Nishijo H
    PLoS One; 2015; 10(3):e0119258. PubMed ID: 25803852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABAergic mechanisms of hippocampal hyperactivity in schizophrenia.
    Heckers S; Konradi C
    Schizophr Res; 2015 Sep; 167(1-3):4-11. PubMed ID: 25449711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamate Decarboxylase 67 Deficiency in a Subset of GABAergic Neurons Induces Schizophrenia-Related Phenotypes.
    Fujihara K; Miwa H; Kakizaki T; Kaneko R; Mikuni M; Tanahira C; Tamamaki N; Yanagawa Y
    Neuropsychopharmacology; 2015 Sep; 40(10):2475-86. PubMed ID: 25904362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: implications for schizophrenia.
    Lin H; Hsu FC; Baumann BH; Coulter DA; Anderson SA; Lynch DR
    Mol Cell Neurosci; 2014 Jul; 61():163-75. PubMed ID: 24983521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parvalbumin, but not calretinin, neurons express high levels of α1-containing GABA
    Równiak M; Kolenkiewicz M; Kozłowska A
    J Chem Neuroanat; 2017 Dec; 86():41-51. PubMed ID: 28834708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Development of Parvalbumin-, Somatostatin-, and Cholecystokinin-Expressing Neurons in Rat Brain following Prenatal Immune Activation and Maternal Iron Deficiency.
    Boksa P; Zhang Y; Nouel D; Wong A; Wong TP
    Dev Neurosci; 2016; 38(5):342-353. PubMed ID: 28214898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fundamental role for hippocampal parvalbumin in the dopamine hyperfunction associated with schizophrenia.
    Boley AM; Perez SM; Lodge DJ
    Schizophr Res; 2014 Aug; 157(1-3):238-43. PubMed ID: 24888524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parvalbumin-containing GABA cells and schizophrenia: experimental model based on targeted gene delivery through adeno-associated viruses.
    Woloszynowska-Fraser MU; Wulff P; Riedel G
    Behav Pharmacol; 2017 Dec; 28(8):630-641. PubMed ID: 29120948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical evaluation of the GABAergic neuronal system in the prefrontal cortex of a DISC1 knockout mouse model of schizophrenia.
    Umeda K; Iritani S; Fujishiro H; Sekiguchi H; Torii Y; Habuchi C; Kuroda K; Kaibuchi K; Ozaki N
    Synapse; 2016 Dec; 70(12):508-518. PubMed ID: 27421906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural alterations in fast-spiking GABAergic interneurons in a model of posttraumatic neocortical epileptogenesis.
    Gu F; Parada I; Shen F; Li J; Bacci A; Graber K; Taghavi RM; Scalise K; Schwartzkroin P; Wenzel J; Prince DA
    Neurobiol Dis; 2017 Dec; 108():100-114. PubMed ID: 28823934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotensin activates GABAergic interneurons in the prefrontal cortex.
    Petrie KA; Schmidt D; Bubser M; Fadel J; Carraway RE; Deutch AY
    J Neurosci; 2005 Feb; 25(7):1629-36. PubMed ID: 15716398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine in postpubertal rats.
    Abekawa T; Ito K; Nakagawa S; Koyama T
    Psychopharmacology (Berl); 2007 Jun; 192(3):303-16. PubMed ID: 17340116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine affects parvalbumin expression during cortical development in vitro.
    Porter LL; Rizzo E; Hornung JP
    J Neurosci; 1999 Oct; 19(20):8990-9003. PubMed ID: 10516317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early-life lead exposure recapitulates the selective loss of parvalbumin-positive GABAergic interneurons and subcortical dopamine system hyperactivity present in schizophrenia.
    Stansfield KH; Ruby KN; Soares BD; McGlothan JL; Liu X; Guilarte TR
    Transl Psychiatry; 2015 Mar; 5(3):e522. PubMed ID: 25756805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.